We support international and ambitious healthcare clients who expect a fast and successful market access and pricing strategy for the launch of their innovative products in Europe.
- Our proven expertise with over 200 successful market access projects in the major European markets
- Unprecedented expertise in the local healthcare markets in Europe
- Substantial professional competence across all indications
- Unique and confidential access to decision makers
Our Network Members
The idea behind the PHAROS network of renowned agencies is, that you have a dedicated team for achieving the best outcomes. Individual accountability is one of the prerequisites to become a leader in the infinite game of market access. These are our main points of contact.
Biodimed Conseils is a French consulting company specialized in market access of drugs including Orphan drug, gene and cell therapy, medical devices, acts and diagnosis. The company was founded in 2015 and is based in Paris.
Biodimed Conseils offers to its customer a comprehensive service for health care products (pharmaceuticals and medical devices or technologies) through their life cycle, and performs projects combining its intimate knowledge and understanding of the Health Care Systems and its expertise in medical and economic evaluation.
The team of consultants with a pharmaceutic background and trained in health economic is able to support pharmaceutical companies from the early market access to the price negotiation.
Biodimed has strong knowledge of process and stakeholder within French HTA and public health agencies enabling to deal with complex regulatory or market access issues and to set the most appropriate strategy.
Côme de Sauvebeuf
P +33 667 946 734
257 rue Paul Doumer • 78510 Triel sur seine, FR
MAP BioPharma is a Market Access specialist accelerating patient access to medicines, devices and diagnostics. Offering a unique integrated approach that supports you throughout the product lifecycle helping you navigate the complexities of the Market Access environment. Our services include:
• MAP Online - a one-stop Market Access portal, which you can rely on for consistent advice and support. MAP Online and the support team can help your
organisation make the right decisions on your Market Access strategy, reducing time and costs. The only validated Market Access portal that explains policies,
processes and stakeholders in 20 countries. A virtual Market Access expert, all the information in one place.
• Consultancy – we are the only integrated consultancy offering that covers patient and political engagement, pricing, and reimbursement strategy, HTA
submissions, HEOR, clinical writing, and legal insights. We draw on deep experience from across the industry and have supported over 200 pricing and
reimbursement procedures since being founded in 2012. Our team give you answers that take the big picture into account, whilst still allowing you to focus
your consultancy spend where it will have the most impact. This blended approach results in 95% of our work resulting in positive client outcomes.
P +44 1480 832 36 0
Upper Pendrill Court • Ermine Street North
North Papworth Everard • Cambridge • CB23 3UY, UK
Spanish National Health System is regionalized, P&R decisions are a central level but access decisions relies in the regions and ultimately to hospitals and primary care centers. Omakase Consulting is a specialised strategic consultancy company that can be the best partner for medium and small size pharmaceutical companies who want to achieve successful and timely Pricing and Market Access (PMA) of their products in Spain. Omakase Consulting have large experience in P&R submissions and negotiations at central level and providing optimal market access (MA) strategies at regional and local level. We are experts in Health Economics, PROs and we extensively use Multi-Criteria Decision Analysis (MCDA) for healthcare evaluation and PMA decision-making. We are committed to deliver our best Omakase to increase the patient chances to get their treatments as early as possible.
Dr. Xavier Badia
P +34 93 189 09 69
Entenza 332-334, 4-1 • 08029-Barcelona, ES
Regulatory Pharma Net (RPN), founded in 1999, is a qualified pharmaceutical service and consulting company based in Italy. RPN highly qualified and experienced team can provide complete support for a successful access to the Italian market, from development to registration, local access and life cycle management.
RPN has experience with a wide range of therapeutic areas and particularly with orphan and advanced-therapy medicinal products. RPN support includes early access and P&MA strategic assessments, advisory boards, stakeholder management and full support with national and regional P&R negotiations.
Dr. Guila Cattani
P +39 050 9134
Regulatory Pharma Net
Corso Italia, 116 • 56125 Pisa, IT
Every patient shall have a fast access to the best possible therapy at a fair price.
For national and international pharmaceutical and medical technology manufacturers, who seek a fast and extensive Market Access at a fair price or strive to maintain an adequate price in their existing market, SmartStep is the consulting company of your choice. SmartStep focuses on the very complex and highly regulated German market and quickly and dynamically develops convincing strategies for all phases and challenges of Market Access. The foundation of SmartStep’s competence is the long-time experience working in the international pharmaceutical industry. Therefore, SmartStep not only performs tasks, but excels at delivering solutions.
Dr. Timm Volmer
P +49 40 609 400 400
Smart Step Consulting
Alter Teichweg 25 a • 22081 Hamburg, DE